Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Bristol-Myers Squibb Co (BMY)  
$44.85 0.15 (0.34%) as of 4:30 Fri 4/26


Download
   
Exchange: New York Stock Exchange
Security Type: Common
Shares Out: 2,250,000,000
Market Cap: 100.91(B)
Last Volume: 21,280,549 Avg Vol: 11,944,728
52 Week Range: $44.7 - $69.08
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Major

Member Indexes:
    S&P COMPOSITE 1500     NYSE COMPOSITE
    S&P 100     S&P 500

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    : 11.3
Insider 3/6 Months : 11.9
Guru Rank Number :  97
Guru Rank Value     : 8.6
Guru Occurances    : 3

 

            6 Months   1 Year   2 Year  
 
Company Profile   Bristol-Myers Squibb is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products on a global basis. Co.'s primary products include: Revlimid®, in which Revlimid (lenalidomide) is an oral immunomodulatory drug that in combination with dexamethasone is indicated for the treatment of patients with multiple myeloma; and Eliquis®, in which Eliquis (apixaban) is an oral Factor Xa inhibitor indicated for the reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE and reduction in risk of recurrence following initial therapy.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 13,571 13,571 13,571
Total Buy Value $0 $672,994 $672,994 $672,994
Total People Bought 0 2 2 2
Total Buy Transactions 0 3 3 3
Total Shares Sold 0 0 69,103 681,397
Total Sell Value $0 $0 $4,525,215 $49,727,684
Total People Sold 0 0 3 6
Total Sell Transactions 0 0 3 12
End Date 2024-01-28 2023-10-27 2023-04-28 2022-04-28

   
Records found: 2225
  Page 8 of 89  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Elkins David V EVP, Chief Financial Officer   •       –      –    2021-12-02 4 OE $0.00 $0 D/D 8,792 88,800     -
   Boerner Christopher S. EVP, Chief Commercial Officer   •       –      –    2021-12-02 4 D $55.41 $74,804 D/D (1,350) 38,512     -
   Boerner Christopher S. EVP, Chief Commercial Officer   •       –      –    2021-12-02 4 OE $0.00 $0 D/D 2,638 39,862     -
   Vessey Rupert EVP, Research & Early Dev.   •       –      –    2021-12-02 4 D $55.41 $249,234 D/D (4,498) 51,258     -
   Vessey Rupert EVP, Research & Early Dev.   •       –      –    2021-12-02 4 OE $0.00 $0 D/D 8,792 55,756     -
   Von Autenried Paul EVP, Chief Information Officer   •       –      –    2021-11-24 4 S $56.92 $987,733 I/I (17,353) 63,536 -36%     
   Von Autenried Paul EVP, Chief Information Officer   •       –      –    2021-11-23 4 S $57.47 $886,072 I/I (15,418) 80,889 -31%     
   Von Autenried Paul EVP, Chief Information Officer   •       –      –    2021-11-22 4 S $57.17 $1,049,813 I/I (18,363) 96,307 -30%     
   Caforio Giovanni Board Chair and CEO   •       •      –    2021-09-20 4 AS $60.64 $1,516,000 D/D (25,000) 483,980 7%     
   Elkins David V EVP, Chief Financial Officer   •       –      –    2021-08-12 4 S $66.88 $6,674,497 D/D (99,691) 80,008 7%     
   Elkins David V EVP, Chief Financial Officer   •       –      –    2021-08-12 4 OE $48.49 $3,394,300 D/D 70,000 139,699     -
   Judge Ann Powell EVP, Chief Human Resources   •       –      –    2021-08-03 4 S $68.57 $1,596,310 D/D (23,280) 47,613 19%     
   Caforio Giovanni Chairman and CEO   •       •      –    2021-08-02 4 S $68.58 $1,371,600 D/D (20,000) 508,980 15%     
   Elkins David V EVP, Chief Financial Officer   •       –      –    2021-08-01 4 D $67.87 $1,610,962 D/D (23,736) 109,699     -
   Elkins David V EVP, Chief Financial Officer   •       –      –    2021-08-01 4 OE $0.00 $0 D/D 46,403 133,435     -
   Leung Sandra EVP, General Counsel   •       –      –    2021-07-30 4 S $68.04 $1,999,696 D/D (29,390) 339,967 15%     
   Von Autenried Paul EVP, Chief Information Officer   •       –      –    2021-07-30 4 GA $0.00 $0 I/I 114,670 114,670     -
   Von Autenried Paul EVP, Chief Information Officer   •       –      –    2021-07-30 4 GD $0.00 $0 D/D 114,670 0     -
   Von Autenried Paul EVP, Chief Information Officer   •       –      –    2021-07-30 4 S $68.06 $1,701,375 D/D (25,000) 114,670 15%     
   Vessey Rupert EVP, Research & Early Dev.   •       –      –    2021-07-30 4 S $68.01 $10,782,154 D/D (158,393) 46,964 15%     
   Vessey Rupert EVP, Research & Early Dev.   •       –      –    2021-07-30 4 OE $44.70 $8,830,108 D/D 150,967 187,617     -
   Dubow Adam SVP,ChiefCompliance&EthicsOff.   •       –      –    2021-07-30 4 S $67.90 $167,441 D/D (2,466) 13,777 15%     
   Santiago Karen Murphy SVP & Controller   •       –      –    2021-07-01 4 D $66.56 $36,408 D/D (547) 14,498     -
   Santiago Karen Murphy SVP & Controller   •       –      –    2021-07-01 4 OE $0.00 $0 D/D 1,069 15,045     -
   Hirawat Samit EVP,Chief Med.Offr.,Drug Dev.   •       –      –    2021-07-01 4 D $66.56 $318,556 D/D (4,786) 11,752     -
  2225 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 8 of 89
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us